WINTON GROUP Ltd Buys Shares of 11,149 MetLife, Inc. $MET

WINTON GROUP Ltd bought a new stake in shares of MetLife, Inc. (NYSE:MET) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 11,149 shares of the financial services provider’s stock, valued at approximately $880,000.

A number of other large investors have also recently bought and sold shares of MET. Norges Bank acquired a new stake in MetLife during the 4th quarter valued at $639,986,000. Vanguard Group Inc. grew its holdings in MetLife by 12.1% during the 4th quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock valued at $5,727,518,000 after buying an additional 7,805,814 shares during the last quarter. Pzena Investment Management LLC grew its holdings in MetLife by 22.9% during the 4th quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock valued at $938,071,000 after buying an additional 2,211,315 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of MetLife by 105.3% during the 3rd quarter. AQR Capital Management LLC now owns 3,305,620 shares of the financial services provider’s stock worth $271,424,000 after purchasing an additional 1,695,563 shares during the period. Finally, First Trust Advisors LP lifted its stake in shares of MetLife by 173.4% during the 3rd quarter. First Trust Advisors LP now owns 1,641,253 shares of the financial services provider’s stock worth $135,190,000 after purchasing an additional 1,040,894 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Trading Up 1.4%

Shares of MET opened at $85.53 on Wednesday. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $55.03 billion, a P/E ratio of 16.58, a price-to-earnings-growth ratio of 0.63 and a beta of 0.78. The stock’s fifty day simple moving average is $78.49 and its 200 day simple moving average is $77.15. MetLife, Inc. has a twelve month low of $67.33 and a twelve month high of $85.76.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.15. The business had revenue of $14.18 billion for the quarter, compared to analyst estimates of $19.49 billion. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The business’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the company posted $1.96 EPS. On average, equities research analysts forecast that MetLife, Inc. will post 9.98 earnings per share for the current year.

MetLife Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 9th. Investors of record on Tuesday, May 12th were given a $0.5925 dividend. This is an increase from MetLife’s previous quarterly dividend of $0.57. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $2.37 annualized dividend and a dividend yield of 2.8%. MetLife’s dividend payout ratio is 45.93%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. TD Cowen reduced their price target on MetLife from $91.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, March 11th. Evercore set a $96.00 price target on MetLife in a research note on Thursday, April 9th. Wall Street Zen lowered MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Keefe, Bruyette & Woods increased their price target on MetLife from $87.00 to $98.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Finally, Mizuho set a $95.00 price target on MetLife in a research note on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $95.31.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: Market commentary says MetLife remains a large, diversified insurer with strong cash flow and international exposure, which can support investor confidence in the stock. Lincoln National vs. MetLife: Which Financial Stock Is a Better Buy in 2026?
• Positive Sentiment: A roundup of life-insurance earnings highlighted MetLife among peers, which can keep attention on the company’s recent operating performance and sector positioning. Q1 earnings roundup: MetLife (NYSE:MET) and the rest of the life insurance segment
• Neutral Sentiment: MetLife Stadium’s LEED Gold certification and World Cup preparations may generate publicity, but they are not direct drivers of MetLife’s insurance earnings. MetLife Stadium Achieves LEED Gold Certification Ahead of FIFA World Cup 2026™
• Neutral Sentiment: Additional World Cup coverage around security, transportation, ticketing, and stadium rankings centers on the venue rather than MetLife’s business operations, so it is unlikely to materially affect the stock. $8.5 million set aside for World Cup security ahead of MetLife Stadium opener
• Neutral Sentiment: Commentary noting MetLife “works” but is not exciting suggests a steady, defensive investment case rather than a catalyst for a sharp move. MetLife: Not Exciting, But It Works
• Negative Sentiment: One article said MetLife Stadium’s travel restrictions could inconvenience World Cup fans, which may create some negative sentiment around the venue, though the impact on MET itself appears limited. World Cup crackdown: MetLife’s new travel restrictions will hit fans hard

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.